TScan Therapeutics, Inc. (TCRX)
1.015
-0.06
(-5.14%)
USD |
NASDAQ |
Dec 12, 16:00
1.03
+0.02
(+1.48%)
After-Hours: 20:00
TScan Therapeutics EPS Diluted (Quarterly): -0.275 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Geron Corp. | -0.0276 |
| Novavax, Inc. | -1.246 |
| XOMA Royalty Corp. | 0.6991 |
| SELLAS Life Sciences Group, Inc. | -0.0626 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.71M |
| Revenue (Quarterly) | 2.511M |
| Total Expenses (Quarterly) | 38.22M |
| Enterprise Value | -28.11M |
| Gross Profit Margin (Quarterly) | 69.45% |
| Profit Margin (Quarterly) | -1.42K% |
| Earnings Yield | -110.3% |
| Normalized Earnings Yield | -109.66 |